KNSA
Kiniksa Pharmaceuticals, Ltd.$53.19-0.35 (-0.66%)Prev Close$53.34·MCap$4.03B·P/E59.18·Vol57.0K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
41
$51.33M
◆
Net Activity
Net Seller
$51.33M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Kiniksa Pharmaceuticals, Ltd. (KNSA) has been exclusively selling, with 0 insider purchases totaling $0.00 and 41 insider sales totaling $51.33M. The most recent insider transaction was by Quart Barry D (Director), who sold $126.0K worth of shares on Feb 10, 2026. Kiniksa Pharmaceuticals, Ltd. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $4.03B.
KNSA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | Quart Barry D | Director | Sell | 2,800 | $45.00 | $126.0K | 0 |
| Feb 9, 2026 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 17,845 | $43.28 | $772.3K | 0 |
| Feb 2, 2026 | Quart Barry D | Director | Sell | 15,960 | $45.22 | $721.6K | 0 |
| Jan 8, 2026 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 12,000 | $41.89 | $502.7K | 0 |
| Dec 15, 2025 | Quart Barry D | Director | Sell | 20,129 | $41.51 | $835.6K | 0 |
| Dec 15, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 12,048 | $41.56 | $500.7K | 0 |
| Dec 8, 2025 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 42,841 | $41.49 | $1.78M | 0 |
| Nov 26, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 200 | $42.89 | $8.6K | 0 |
| Nov 17, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 12,470 | $41.24 | $514.2K | 0 |
| Nov 12, 2025 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 19,900 | $40.94 | $814.7K | 0 |
| Oct 31, 2025 | Paolini John F. | CHIEF MEDICAL OFFICER | Sell | 82,542 | $37.14 | $3.07M | 0 |
| Oct 28, 2025 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 100 | $41.00 | $4.1K | 0 |
| Oct 20, 2025 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Sell | 50,490 | $38.87 | $1.96M | 0 |
| Oct 20, 2025 | Patel Sanj K | CHAIRMAN & CEO | Sell | 257,969 | $38.86 | $10.02M | 0 |
| Oct 14, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 12,368 | $37.67 | $465.8K | 0 |
| Oct 4, 2025 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Sell | 85 | $38.49 | $3.3K | 0 |
| Sep 29, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 42,000 | $38.33 | $1.61M | 0 |
| Sep 15, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 16,400 | $36.46 | $598.0K | 0 |
| Sep 4, 2025 | Moat Ross | CHIEF CORP. & COMM. OFFICER | Sell | 3,523 | $35.31 | $124.4K | 0 |
| Sep 4, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 98,660 | $35.54 | $3.51M | 0 |
| Sep 1, 2025 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Sell | 15,657 | $34.46 | $539.5K | 0 |
| Sep 1, 2025 | Moat Ross | CHIEF CORP. & COMM. OFFICER | Sell | 3,300 | $33.61 | $110.9K | 0 |
| Sep 1, 2025 | Paolini John F. | CHIEF MEDICAL OFFICER | Sell | 3,676 | $33.67 | $123.8K | 0 |
| Sep 1, 2025 | Patel Sanj K | CHAIRMAN & CEO | Sell | 14,160 | $33.67 | $476.7K | 0 |
| Sep 1, 2025 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 3,820 | $33.68 | $128.6K | 0 |
| Sep 1, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 19,063 | $35.12 | $669.5K | 0 |
| Aug 18, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 16,200 | $33.77 | $547.1K | 0 |
| Aug 12, 2025 | Malley Thomas | Director | Sell | 177,769 | $32.96 | $5.86M | 0 |
| Aug 6, 2025 | Paolini John F. | CHIEF MEDICAL OFFICER | Sell | 29,325 | $32.55 | $954.5K | 0 |
| Aug 4, 2025 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 18,889 | $32.89 | $621.3K | 0 |
| Jul 15, 2025 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Sell | 17,000 | $32.35 | $550.0K | 0 |
| Jul 15, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 138,614 | $33.20 | $4.60M | 0 |
| Jul 14, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 18,900 | $28.72 | $542.8K | 0 |
| Jun 16, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 17,300 | $28.28 | $489.2K | 0 |
| Jun 9, 2025 | Quart Barry D | Director | Sell | 27,448 | $30.35 | $833.0K | 0 |
| Jun 9, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 70,867 | $30.48 | $2.16M | 0 |
| Jun 3, 2025 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Sell | 15,211 | $28.75 | $437.3K | 0 |
| Jun 3, 2025 | Moat Ross | CHIEF COMMERCIAL OFFICER | Sell | 27,594 | $29.02 | $800.8K | 0 |
| Jun 3, 2025 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 18,299 | $28.80 | $527.0K | 0 |
| May 23, 2025 | Patel Sanj K | CHAIRMAN & CEO | Sell | 86,270 | $27.24 | $2.35M | 0 |
| May 20, 2025 | Patel Sanj K | CHAIRMAN & CEO | Sell | 2,349 | $27.02 | $63.5K | 0 |
| May 19, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 12,000 | $26.41 | $316.9K | 0 |
| May 13, 2025 | Patel Sanj K | CHAIRMAN & CEO | Sell | 2,872 | $27.03 | $77.6K | 0 |
| May 7, 2025 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Sell | 17,647 | $26.69 | $471.0K | 0 |
| May 7, 2025 | Paolini John F. | CHIEF MEDICAL OFFICER | Sell | 200 | $27.00 | $5.4K | 0 |
| May 7, 2025 | Patel Sanj K | CHAIRMAN & CEO | Sell | 8,095 | $27.04 | $218.9K | 0 |
| May 1, 2025 | Moat Ross | CHIEF COMMERCIAL OFFICER | Sell | 10,122 | $28.00 | $283.4K | 0 |
| Apr 29, 2025 | Moat Ross | CHIEF COMMERCIAL OFFICER | Sell | 87,269 | $25.96 | $2.27M | 0 |
| Apr 29, 2025 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 88,395 | $26.56 | $2.35M | 0 |
| Apr 26, 2025 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 479 | $21.36 | $10.2K | 0 |
Showing 1–50 of 74
1 / 2
KNSA Insider Buying Activity
The following table shows recent insider purchases of Kiniksa Pharmaceuticals, Ltd. (KNSA) stock reported via SEC Form 4 filings.
No insider buying activity found for KNSA in the last 12 months.
KNSA Insider Selling Activity
The following table shows recent insider sales of Kiniksa Pharmaceuticals, Ltd. (KNSA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | Quart Barry D | Director | Sell | 2,800 | $45.00 | $126.0K | 0 |
| Feb 9, 2026 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 17,845 | $43.28 | $772.3K | 0 |
| Feb 2, 2026 | Quart Barry D | Director | Sell | 15,960 | $45.22 | $721.6K | 0 |
| Jan 8, 2026 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 12,000 | $41.89 | $502.7K | 0 |
| Dec 15, 2025 | Quart Barry D | Director | Sell | 20,129 | $41.51 | $835.6K | 0 |
| Dec 15, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 12,048 | $41.56 | $500.7K | 0 |
| Dec 8, 2025 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 42,841 | $41.49 | $1.78M | 0 |
| Nov 26, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 200 | $42.89 | $8.6K | 0 |
| Nov 17, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 12,470 | $41.24 | $514.2K | 0 |
| Nov 12, 2025 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 19,900 | $40.94 | $814.7K | 0 |
| Oct 31, 2025 | Paolini John F. | CHIEF MEDICAL OFFICER | Sell | 82,542 | $37.14 | $3.07M | 0 |
| Oct 28, 2025 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 100 | $41.00 | $4.1K | 0 |
| Oct 20, 2025 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Sell | 50,490 | $38.87 | $1.96M | 0 |
| Oct 20, 2025 | Patel Sanj K | CHAIRMAN & CEO | Sell | 257,969 | $38.86 | $10.02M | 0 |
| Oct 14, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 12,368 | $37.67 | $465.8K | 0 |
| Oct 4, 2025 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Sell | 85 | $38.49 | $3.3K | 0 |
| Sep 29, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 42,000 | $38.33 | $1.61M | 0 |
| Sep 15, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 16,400 | $36.46 | $598.0K | 0 |
| Sep 4, 2025 | Moat Ross | CHIEF CORP. & COMM. OFFICER | Sell | 3,523 | $35.31 | $124.4K | 0 |
| Sep 4, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 98,660 | $35.54 | $3.51M | 0 |
| Sep 1, 2025 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Sell | 15,657 | $34.46 | $539.5K | 0 |
| Sep 1, 2025 | Moat Ross | CHIEF CORP. & COMM. OFFICER | Sell | 3,300 | $33.61 | $110.9K | 0 |
| Sep 1, 2025 | Paolini John F. | CHIEF MEDICAL OFFICER | Sell | 3,676 | $33.67 | $123.8K | 0 |
| Sep 1, 2025 | Patel Sanj K | CHAIRMAN & CEO | Sell | 14,160 | $33.67 | $476.7K | 0 |
| Sep 1, 2025 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 3,820 | $33.68 | $128.6K | 0 |
| Sep 1, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 19,063 | $35.12 | $669.5K | 0 |
| Aug 18, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 16,200 | $33.77 | $547.1K | 0 |
| Aug 12, 2025 | Malley Thomas | Director | Sell | 177,769 | $32.96 | $5.86M | 0 |
| Aug 6, 2025 | Paolini John F. | CHIEF MEDICAL OFFICER | Sell | 29,325 | $32.55 | $954.5K | 0 |
| Aug 4, 2025 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 18,889 | $32.89 | $621.3K | 0 |
| Jul 15, 2025 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Sell | 17,000 | $32.35 | $550.0K | 0 |
| Jul 15, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 138,614 | $33.20 | $4.60M | 0 |
| Jul 14, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 18,900 | $28.72 | $542.8K | 0 |
| Jun 16, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 17,300 | $28.28 | $489.2K | 0 |
| Jun 9, 2025 | Quart Barry D | Director | Sell | 27,448 | $30.35 | $833.0K | 0 |
| Jun 9, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 70,867 | $30.48 | $2.16M | 0 |
| Jun 3, 2025 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Sell | 15,211 | $28.75 | $437.3K | 0 |
| Jun 3, 2025 | Moat Ross | CHIEF COMMERCIAL OFFICER | Sell | 27,594 | $29.02 | $800.8K | 0 |
| Jun 3, 2025 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 18,299 | $28.80 | $527.0K | 0 |
| May 23, 2025 | Patel Sanj K | CHAIRMAN & CEO | Sell | 86,270 | $27.24 | $2.35M | 0 |
| May 20, 2025 | Patel Sanj K | CHAIRMAN & CEO | Sell | 2,349 | $27.02 | $63.5K | 0 |
| May 19, 2025 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | 12,000 | $26.41 | $316.9K | 0 |
| May 13, 2025 | Patel Sanj K | CHAIRMAN & CEO | Sell | 2,872 | $27.03 | $77.6K | 0 |
| May 7, 2025 | Megna Michael R | CHIEF ACCOUNTING OFFICER | Sell | 17,647 | $26.69 | $471.0K | 0 |
| May 7, 2025 | Paolini John F. | CHIEF MEDICAL OFFICER | Sell | 200 | $27.00 | $5.4K | 0 |
| May 7, 2025 | Patel Sanj K | CHAIRMAN & CEO | Sell | 8,095 | $27.04 | $218.9K | 0 |
| May 1, 2025 | Moat Ross | CHIEF COMMERCIAL OFFICER | Sell | 10,122 | $28.00 | $283.4K | 0 |
| Apr 29, 2025 | Moat Ross | CHIEF COMMERCIAL OFFICER | Sell | 87,269 | $25.96 | $2.27M | 0 |
| Apr 29, 2025 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 88,395 | $26.56 | $2.35M | 0 |
| Apr 26, 2025 | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 479 | $21.36 | $10.2K | 0 |
KNSA Insiders
Similar Stocks to KNSA
VRTX
Vertex Pharmaceuticals Incorporated
$433.25-0.35%
$114.32B
REGN
Regeneron Pharmaceuticals, Inc.
$639.22+1.36%
$73.44B
ALNY
Alnylam Pharmaceuticals, Inc.
$294.26-0.21%
$39.18B
RVMD
Revolution Medicines, Inc.
$152.00+3.11%
$31.78B
INSM
Insmed Incorporated
$108.12+0.65%
$25.06B
UTHR
United Therapeutics Corporation
$567.68+0.21%
$24.13B
ROIV
Roivant Sciences Ltd.
$32.19+13.75%
$20.96B
MRNA
Moderna, Inc.
$47.86+4.57%
$19.46B